Exblifep is a combination of a novel extended-spectrum beta-lactamase inhibitor, enmetazobactam, and the fourth-generation cephalosporin cefepime.
BioSpace takes a look at some of the investigational products that could, one day, provide relief for migraine sufferers.
There are 1,969,610 people registered with a GP who have non-diabetic hyperglycaemia, a condition which puts people at high risk of type II.
GSK initially announced plans to make its pandemic vaccine adjuvant platform technology available at the beginning of February.
Alzheimer’s is a complex disease and one of the largest challenges facing healthcare today, with lots of failed treatments in past pipelines.
In two head-to-head studies, ofatumumab demonstrated superiority over Aubagio in patients with relapsing forms of multiple sclerosis.
The divestment is expected to complete in the first quarter of 2020, subject to customary closing conditions and regulatory clearances.
The ASRS issued a note to its members about concerns regarding reports of vasculitis, an inflammation of the blood vessels and other complications that can lead to the loss...
In addition to the settlement and bankruptcy, Mallinckrodt entered into a debt refinancing agreement, including an $800 million loan that will be used to repay some outstanding debt and...
In its announcement, Bicycle did not identify the cancer targets it will focus on in its collaboration with Genentech.